摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-hydroxyphenyl)-5-phenylpenta-1,4-dien-3-one | 4942-09-0

中文名称
——
中文别名
——
英文名称
1-(2-hydroxyphenyl)-5-phenylpenta-1,4-dien-3-one
英文别名
5t-phenyl-1t-(2-hydroxy-phenyl)-pentadien-(1.4)-one-(3);1-(2-hydroxy-phenyl)-5-phenyl-penta-1,4-dien-3-one;5t-Phenyl-1t-(2-hydroxy-phenyl)-pentadien-(1.4)-on-(3);1-(2-Hydroxy-phenyl)-5-phenyl-penta-1,4-dien-3-on;1-(2-Hydroxyphenyl)-5-phenyl-1,4-pentadien-3-one;(1E,4E)-1-(2-hydroxyphenyl)-5-phenylpenta-1,4-dien-3-one
1-(2-hydroxyphenyl)-5-phenylpenta-1,4-dien-3-one化学式
CAS
4942-09-0
化学式
C17H14O2
mdl
——
分子量
250.297
InChiKey
FDFRSFSHWUDRTJ-DCIPZJNNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(2-hydroxyphenyl)-5-phenylpenta-1,4-dien-3-one亚磷酸二甲酯三乙胺 作用下, 以 四氯化碳 为溶剂, 反应 24.5h, 以42%的产率得到dimethyl (2-((1E,4E)-3-oxo-5-phenylpenta-1,4-dien-1-yl)phenyl) phosphate
    参考文献:
    名称:
    新型磷酸化 Penta-1,4-dien-3-one 衍生物:设计、合成和生物活性
    摘要:
    设计并合成了一系列新型磷酸化penta-1,4-dien-3-one 衍生物。所有标题化合物的结构均通过 1H-NMR、13C-NMR、31P-NMR 和高分辨率质谱 (HRMS) 测定。生物测定结果表明,几种标题化合物表现出显着的抗菌和抗病毒活性。其中,化合物 3g 对黄单胞菌 pv 表现出显着的抗菌活性。稻瘟病菌 (Xoo) 的 50% 有效浓度 (EC50) 值为 8.6 μg/mL,显着优于双甲噻唑 (BT) (58.8 μg/mL) 和硫代二唑铜 (TC) (78.7 μg/mL)。此外,化合物3h对烟草花叶病毒(TMV)表现出显着的保护活性,EC50值为104.2 μg/mL,优于宁南霉素(386.2 μg/mL)。此外,还研究了关于化合物 3h 和 3j 与 TMV 外壳蛋白 (TMV CP) 相互作用的微型热泳和分子对接实验。化合物3h和3j以0.028和0.23 μmol/L的解离常数与TMV
    DOI:
    10.3390/molecules24050925
  • 作为产物:
    描述:
    水杨醛 在 sodium hydroxide 作用下, 以 乙醇 为溶剂, 生成 1-(2-hydroxyphenyl)-5-phenylpenta-1,4-dien-3-one
    参考文献:
    名称:
    新型3-(((2-((1 E,4 E)-3-Oxo-5-arylpenta-1,4-dien-1-yl)phenoxy)methyl)-4(3 H)-的合成及抗病毒活性喹唑啉酮衍生物
    摘要:
    一系列新颖的3-((2-((1 E,4 E)-3-氧代-5-芳基戊-1,4-二烯-1-基)苯氧基)甲基)-4(3 H)-喹唑啉酮衍生物被设计和合成。抗病毒生物测定法表明,与市售药物宁南霉素相比,一些化合物在体内对烟草花叶病毒(TMV)表现出更高的抗病毒活性。特别地,化合物A 5,A 12,A 25和A 27在体内对TMV具有可观的治愈性生物活性,50%有效浓度范围为132.25至156.10μg/ mL。这些值优于宁南霉素(281.22μg/ mL)的值,表明新颖的4(3 H含有1,4-戊二烯-3-一个部分的)-喹唑啉酮衍生物可以有效地控制TMV。在野外研究中评估抗病毒特性以及这些衍生物增强的抗病毒活性的潜在机制是未来研究的有趣话题。
    DOI:
    10.1021/jf502162y
点击查看最新优质反应信息

文献信息

  • A novel and facile stereocontrolled synthetic method for polyhydro-quinolines and pyridopyridazines via a diene-transmissive Diels–Alder reaction involving inverse electron-demand hetero Diels–Alder cycloaddition of cross-conjugated azatrienes
    作者:Satoru Kobayashi、Tomoki Furuya、Takashi Otani、Takao Saito
    DOI:10.1016/j.tet.2008.07.102
    日期:2008.10
    selectivity. The N-sulfonylazatrienes tethering an ortho-cinnamyloxyphenyl dienophile at the triene terminal underwent an initial intramolecular hetero Diels–Alder reaction of the inverse electron-demand type. The subsequent second Diels–Alder reaction of the formed mono-cycloadducts completed the diene-transmissive hetero Diels–Alder protocol to give benzopyrano[3,4-c]quinolines in a highly stereoselective
    在加热或存在路易斯酸(TMSOTf)的情况下,在氮原子上带有吸电子磺酰基或苯甲酰基的交叉共轭氮杂三烯进行了最初的反电子需求杂Diels-Alder逆反应,与富电子的亲二烯体(乙烯基醚,乙烯基硫醚和链烯基醚),以产生具有高内选择性的1:1环加合物。如此获得的初始环加合物在新形成的二烯单元上通过电子不足的亲二烯体选择性地进行第二次Diels-Alder反应,得​​到具有高非对映体π选择性的双双环加合物八氢喹啉。所述Ñ -sulfonylazatrienes栓系的邻三烯末端的-肉桂酰氧基苯基二烯亲生体经历了电子反型的初始分子内杂Diels-Alder反应。形成的单环加合物的随后第二次Diels-Alder反应完成了二烯可传递的杂Diels-Alder方案,以高度立体选择性的方式生成了苯并吡喃并[3,4- c ]喹啉。
  • Design, synthesis, and antiviral activity of novel rutin derivatives containing 1, 4-pentadien-3-one moiety
    作者:Yu Han、Yan Ding、Dandan Xie、Deyu Hu、Pei Li、Xiangyang Li、Wei Xue、Linhong Jin、Baoan Song
    DOI:10.1016/j.ejmech.2015.01.017
    日期:2015.3
    Rutin (compound 5) and some compounds (compounds 1-4 and 6) were isolated from Artemisia princeps Pamp (A. prirtceps Pamp.) and a series of novel rutin derivatives containing 1,4-pentadien-3-one moiety were designed and synthesized. The target compounds were characterized by proton nuclear magnetic resonance spectroscopy (H-1 NMR), carbon nuclear magnetic resonance spectroscopy (C-13 NMR), and ESI-MS. Bioassay results indicated that some of the compounds showed good to excellent antiviral activities against tobacco mosaic virus (TMV) and cucumber mosaic virus (CMV) at 500 mu g/mL in vivo. The 50% effective concentrations (EC50) of the compound 7r against CMV was 394.78 mu g/mL, which was better than that of Ningnanmycin (432.22 mu g/mL). These results indicated that novel rutin derivatives containing 1,4-pentadien-3-one moiety can effectively control CMV. (C) 2015 Elsevier Masson SAS. All rights reserved.
  • Antiviral activity and interaction mechanisms study of novel glucopyranoside derivatives
    作者:Meihang Chen、Deyu Hu、Xiangyang Li、Song Yang、Weiying Zhang、Pei Li、Baoan Song
    DOI:10.1016/j.bmcl.2015.07.068
    日期:2015.9
    Novel glucopyranoside derivatives were synthesized and evaluated for their antiviral activities against tobacco mosaic virus (TMV). Bioassay results indicated that some of the target compounds exhibited good in vivo antiviral activities against TMV. Among the title compounds, f6 showed appreciable inactivation effect against TMV, with the 50% effective concentration value (EC50) of 52.9 mu g/mL, which was better than that of ribavirin (145.1 mu g/mL). In addition, interaction between f6 and TMV-CP was characterized by fluorescence spectroscopy, isothermal titration calorimetry (ITC), and microscale thermophoresis (MST). Results showed that f6 bound to TMV-CP with micromole affinity, and thermodynamic parameters suggested that this interaction was typically endothermic and spontaneous, with 1: 1.53 ratio of TMV-CP to f6. Thus, the synthesized glucopyranoside derivatives containing 1,4-pentadien- 3-one moiety could be promising antiviral agents. (C) 2015 Elsevier Ltd. All rights reserved.
  • v. Kostanecki; Maron, Chemische Berichte, 1898, vol. 31, p. 728
    作者:v. Kostanecki、Maron
    DOI:——
    日期:——
  • MTOR-INDEPENDENT ACTIVATOR OF TFEB FOR AUTOPHAGY ENHANCEMENT AND USES THEREOF
    申请人:Hong Kong Baptist University
    公开号:EP3113767B1
    公开(公告)日:2020-12-09
查看更多